Initial Quarterly Holdings Report by Institutional Manager - Form 13F-HR
Targeting the RAS/RAF/PI3K pathway for CD40 induction in melanoma cells[...]
09/17/2021 | Press release | Distributed by Public on 09/17/2021 13:44
Please select the service you want to use:
Smartlinks | Media Central Corporation Inc. | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Arts and Culture | Entertainment | Media | Public Companies | Media and Publishing Companies | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | OTC Markets | Canadian Securities Exchange (CSE) | Aequitas NEO Exchange | OmegaATS | Lynx ATS | Nasdaq CXC | Nasdaq CX2
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact